HIGH

STAQ Pharma Hydromorphone HCl PF 10mg/50mL IV Injection Recall for Labeling Errors (2025)

STAQ Pharma’s Hydromorphone HCl PF 10mg/50mL IV injection recall affects nationwide distribution in the United States. The recall cites labeling errors involving incorrect or missing lot and expiration dates. Healthcare providers and patients must stop using the product and follow guidance from STAQ Pharma or their clinician.

Quick Facts at a Glance

Recall Date
October 9, 2025
Hazard Level
HIGH
Brand
STAQ Pharma
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Labeling: Incorrect or Missing Lot and/or Exp Date

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact STAQ Pharma, Inc. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Hydromorphone HCl PF is a prescription opioid analgesic prepared for intravenous use in medical settings. Correct lot and expiry labeling is essential for patient safety.

Why This Is Dangerous

Incorrect or missing lot and expiry data can lead to incorrect identification or administration of expired product, posing patient safety risks.

Industry Context

This recall is not presented as part of a broader industry pattern.

Real-World Impact

Hospitals and clinics must verify labeling before use; patients could experience treatment delays or dosing errors during recall replacements.

Practical Guidance

How to identify if yours is affected

  1. Locate the product label for Lot 25104595A and Expiry 27DEC2025
  2. Cross-check NDC 73177-0104-05 on the packaging
  3. Review inventory logs for recent distributions of this lot

Where to find product info

Label on syringe packaging and accompanying documentation; NDC on the label

What timeline to expect

Not specified; follow STAQ Pharma recall communications for remediation timelines

If the manufacturer is unresponsive

  • Document all attempts to contact STAQ Pharma
  • Coordinate with hospital recalls office or pharmacists
  • File a recall complaint with FDA if necessary

How to prevent similar issues

  • Implement double-checks for lot/expiry during receiving and administration
  • Use electronic inventory controls with expiry warnings
  • Regularly review FDA recall notices for drug labeling issues

Documentation advice

Keep copy of recall notice, lot and expiry records, and all correspondence with STAQ Pharma

Product Details

Model numbers/identifiers: Lot 25104595A; Expiry 27DEC2025. Sold nationwide through medical facilities and distributors. NDC 73177-0104-05. Manufacturer: STAQ Pharma, Inc., 14135 E 42nd Ave, Denver, CO.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Hydromorphone HCl PF, 10mg/50mL in saline for IV use
  • NDC 73177-0104-05
  • Lot 25104595A
  • Expiry 27DEC2025
  • Nationwide U.S. distribution
  • Active recall as of 2025-10-22

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
25104595A
Expiry 27DEC2025
Affected States
ALL
Report Date
October 22, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more
Vehicles & Parts
HIGH

Chrysler Pacifica Radio Recall 2025 Over Rearview Camera Display Issue

Chrysler is recalling 2024-2025 Pacifica minivans after a radio installed during production could fail to display the rearview camera image. Dealers will replace the radio at no cost. Owner letters were mailed August 7, 2025. Contact Chrysler customer service at 800-853-1403 for details.

Chrysler
A rearview
Read more